Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study-Reference-Cited by-同舟云学术

Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study

Published:2013-11-20 Issue:2 Volume:109 Page:262-272
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

van Emmerik-van Oortmerssen Katelijne¹²³,van de Glind Geurt²⁴,Koeter Maarten W. J.²,Allsop Steve⁵,Auriacombe Marc⁶,Barta Csaba⁷,Bu Eli Torild H.⁸,Burren Yuliya⁹,Carpentier Pieter-Jan¹⁰,Carruthers Susan⁵,Casas Miguel¹¹,Demetrovics Zsolt¹²,Dom Geert¹³,Faraone Stephen V.¹⁴¹⁵,Fatseas Melina⁶,Franck Johan¹⁶,Johnson Brian¹⁴¹⁵,Kapitány-Fövény Máté¹²¹⁷,Kaye Sharlene¹⁸,Konstenius Maija¹⁶,Levin Frances R.¹⁹,Moggi Franz⁹²⁰,Møller Merete²¹,Ramos-Quiroga J. Antoni¹¹,Schillinger Arild²¹,Skutle Arvid⁸,Verspreet Sofie¹³,van den Brink Wim²,Schoevers Robert A.³,

Affiliation:

1. Arkin Mental Health and Addiction Treatment Center; Amsterdam the Netherlands

2. Amsterdam Institute for Addiction Research; Department of Psychiatry; Academic Medical Center; University of Amsterdam; Amsterdam the Netherlands

3. Department of Psychiatry; University Medical Center Groningen; University of Groningen; Groningen the Netherlands

4. Trimbos-Instituut and ICASA Foundation; Utrecht the Netherlands

5. National Drug Research Institute/Curtin University of Technology; Perth Western Australia Australia

6. Laboratoire de psychiatrie Département d'addictologie; Université de Bordeaux; Bordeaux France

7. Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry; Semmelweis University; Budapest Hungary

8. Bergen Clinics Foundation; Bergen Norway

9. University Hospital of Psychiatry; Bern Switzerland

10. Reinier van Arkel groep; 's-Hertogenbosch the Netherlands

11. Servei de Psiquiatria; Hospital Universitari Vall d'Hebron; CIBERSAM; Department of Psychiatry; Universitat Autònoma de Barcelona; Barcelona Spain

12. Institute of Psychology; Eötvös Loránd University; Budapest Hungary

13. Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA); PC Alexian Brothers; Boechout Belgium

14. Department of Psychiatry; SUNY Upstate Medical University; Syracuse NY USA

15. Department of Neuroscience and Physiology; SUNY Upstate Medical University; Syracuse NY USA

16. Department of Clinical Neuroscience; Division of Psychiatry; Karolinska Institutet; Stockholm Sweden

17. Nyírő Gyula Hospital Drug Outpatient and Prevention Center; Budapest Hungary

18. National Drug and Alcohol Research Centre; University of New South Wales; Sydney New South Wales Australia

19. Columbia University/the New York State Psychiatric Institute; New York NY USA

20. Department of Psychology; University of Fribourg; Fribourg Switzerland

21. Department for Substance Abuse Treatment; Ostfold Hospital Trust; Fredrikstad Norway

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/add.12370/fullpdf

Reference49 articles.

1. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis;Emmerik-van Oortmerssen;Drug Alcohol Depend,2012

2. An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program;Chen;Drug Alcohol Depend,2011

3. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment;Chan;J Subst Abuse Treat,2008

4. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC);Bernardi;Psychol Med,2012

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Methylphenidate on Cognition in Patients with Comorbid Attention Deficit/Hyperactivity Disorder and Amphetamine Use Disorder: An Exploratory Single-Blinded within-Subject Study;European Addiction Research;2023-11-29

2. Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management;Expert Review of Clinical Pharmacology;2023-08-22

3. Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study;BMC Psychiatry;2023-06-29

4. Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician;Journal of Clinical Medicine;2023-04-24

5. Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement;World Journal of Psychiatry;2023-03-19